UnitedHealth Group (UNH) FY2025 results: revenue $447.6 billion, up 11.8% on the year
UnitedHealth Group Inc. (UNH) reported revenue of $447.6 billion for fiscal 2025, the year ended 31 December 2025, up 11.8% on the year before. Net income was $12.1 billion, down 16.3%, and diluted earnings per share $13.23. The figures are the company's own, from the 10-K it filed with the SEC on 2 March 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 21 new.
- Revenue rose 12% in 2025: Full-year revenues reached $447.6 billion, up $47.3 billion from 2024. Fourth-quarter revenues were $113.2 billion against $100.8 billion a year earlier.
- $2.8 billion charge hit 2025 earnings: Full-year earnings from operations of $19.0 billion included a $2.8 billion charge. Adjusted earnings from operations were $21.7 billion, excluding that charge.
- Operating margin fell to 2.7%: UnitedHealthcare earnings from operations were $9.4 billion, a 2.7% margin against 5.2% in 2024. Management cited Biden-era Medicare funding reductions, Inflation Reduction Act effects and medical cost trends.
- Optum Health swung to a loss: Optum Health revenue fell 3% to $102.0 billion and recorded earnings from operations of $(278) million, against $7.8 billion in 2024. Adjusted earnings were $2.3 billion.
- Adjusted medical care ratio rose: The adjusted medical care ratio was 88.9% for 2025, compared with 85.5% in 2024. The reported 89.1% included a 20 basis point negative effect from loss contracts in the charge.
From this 10-K
UnitedHealth Group runs two businesses. UnitedHealthcare sells health insurance, taking a premium and carrying the cost of members' medical care. Optum sells health services to the rest of the system, including care delivery, data and technology, and pharmacy benefits, and it serves other insurers as well as its own sister company. Almost all of it is in the United States.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 447,567 | 400,278 | 371,622 | +11.8% | |
| Cost of revenue | 50,655 | 46,694 | 38,770 | +8.5% | |
| Gross profit | 396,912 | 353,584 | 332,852 | +12.3% | |
| Gross margin | 88.7% | 88.3% | 89.6% | ||
| Selling, general and administrative | 59,592 | 53,013 | 54,628 | +12.4% | |
| Operating income | 18,964 | 32,287 | 32,358 | -41.3% | |
| Operating margin | 4.2% | 8.1% | 8.7% | ||
| Interest expense | 4,002 | 3,906 | 3,246 | +2.5% | |
| Pre-tax income | 14,697 | 20,071 | 29,112 | -26.8% | |
| Income tax | 1,890 | 4,829 | 5,968 | -60.9% | |
| Effective tax rate | 12.9% | 24.1% | 20.5% | ||
| Net income | 12,056 | 14,405 | 22,381 | -16.3% | |
| Net margin | 2.7% | 3.6% | 6.0% | ||
| Diluted EPS | $13.23 | $15.51 | $23.86 | -14.7% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 19,697 | 24,204 | 29,068 | -18.6% | |
| Capital expenditure | 3,622 | 3,499 | 3,386 | +3.5% | |
| Free cash flow | 16,075 | 20,705 | 25,682 | -22.4% | |
| Free cash flow margin | 3.6% | 5.2% | 6.9% | ||
| Cash from investing | -8,685 | -20,527 | -15,574 | ||
| Cash from financing | -11,644 | -3,512 | -11,529 | ||
| Depreciation and amortisation | 4,361 | 4,099 | 3,972 | +6.4% | |
| Share-based compensation | 971 | 1,018 | 1,059 | -4.6% | |
| Buybacks | 5,545 | 9,000 | 8,000 | -38.4% | |
| Dividends paid | 7,916 | 7,533 | 6,761 | +5.1% | |
| Dividend per share | $8.73 | $8.18 | $7.29 | +6.7% | |
| Diluted shares, weighted | 911m | 929m | 938m | -1.9% | |
| Shares outstanding at period end | 906m | 915m | 924m | -1.0% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | 100,090 | 98,268 | 94,421 | +1.9% | |
| Redeemable equity | 1,608 | 4,323 | 4,498 | -62.8% | |
| Debt | 78,389 | 76,904 | 62,537 | +1.9% | |
| Other liabilities | 129,494 | 118,783 | 112,264 | +9.0% | |
| Total liabilities and equity | 309,581 | 298,278 | 273,720 | +3.8% | |
| Fixed assets | 10,762 | 10,553 | 11,450 | +2.0% | |
| Goodwill | 110,499 | 106,734 | 103,732 | +3.5% | |
| Intangible assets | 20,474 | 23,268 | 15,194 | -12.0% | |
| Investments | 58,007 | 56,155 | 51,810 | +3.3% | |
| Cash and equivalents | 24,365 | 25,312 | 25,427 | -3.7% | |
| Receivables | 23,018 | 22,365 | 21,276 | +2.9% | |
| Inventory | 3,300 | 3,800 | 2,800 | -13.2% | |
| Other assets | 59,156 | 50,091 | 42,031 | +18.1% | |
| Total assets | 309,581 | 298,278 | 273,720 | +3.8% |
10-K for the year ended 31 December 2025, filed 2 March 2026: the filing.